CS
FLNA

Credit Suisse’s Filana Therapeutics FLNA Stock Holding History

Credit Suisse’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.04M Buy
51,154
+1,209
+2% +$27.9K ﹤0.01% 2241
2023
Q4 		$1.12M Buy
49,945
+2,322
+5% +$49.1K ﹤0.01% 2265
2023
Q3 		$792K Sell
47,623
-1,616
-3% -$32K ﹤0.01% 2429
2023
Q2 		$1.21M Buy
49,239
+4,516
+10% +$109K ﹤0.01% 2258
2023
Q1 		$1.08M Buy
44,723
+2,707
+6% +$75K ﹤0.01% 2278
2022
Q4 		$1.24M Buy
42,016
+8,270
+25% +$297K ﹤0.01% 2186
2022
Q3 		$1.41M Sell
33,746
-4,110
-11% -$111K ﹤0.01% 2081
2022
Q2 		$1.07M Buy
37,856
+1,239
+3% +$31.3K ﹤0.01% 2344
2022
Q1 		$1.36M Buy
36,617
+3,589
+11% +$152K ﹤0.01% 2333
2021
Q4 		$1.44M Buy
33,028
+6,298
+24% +$330K ﹤0.01% 3037
2021
Q3 		$1.66M Buy
26,730
+5,192
+24% +$433K ﹤0.01% 2955
2021
Q2 		$1.84M Buy
+21,538
New +$1.15M ﹤0.01% 2939
2015
Q3 		– Sell
-6,925
Closed -$84K – 4444
2015
Q2 		$84K Buy
6,925
+4,237
+158% +$58.1K ﹤0.01% 4409
2015
Q1 		$36K Sell
2,688
-2,978
-53% -$40.2K ﹤0.01% 4297
2014
Q4 		$80K Sell
5,666
-4,473
-44% -$77.4K ﹤0.01% 4473
2014
Q3 		$277K Sell
10,139
-2,283
-18% -$69.4K ﹤0.01% 3968
2014
Q2 		$500K Buy
12,422
+1,131
+10% +$41.9K ﹤0.01% 3822
2014
Q1 		$435K Buy
+11,291
New +$399K ﹤0.01% 3816
2013
Q3 		– Sell
-16,424
Closed -$255K – 4347
2013
Q2 		$255K Buy
+16,424
New +$347K ﹤0.01% 3727

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Credit Suisse's FLNA Position: Q1 2024 in Review

Credit Suisse increased its Filana Therapeutics (FLNA) stake by 2.4% in Q1 2024, buying an estimated $27.9K and bringing the position to 51,154 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

Credit Suisse first reported a position in FLNA in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.84M in Q2 2021. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Credit Suisse held 51,154 shares of Filana Therapeutics worth $1.04M as of Q1 2024.
  • Credit Suisse bought 1,209 Filana Therapeutics shares in Q1 2024, an estimated $27.9K.
  • Filana Therapeutics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2241 holding.
  • Credit Suisse first reported a position in Filana Therapeutics in Q2 2013 and has held it in 19 quarters since.
  • Credit Suisse's Filana Therapeutics position peaked at $1.84M in Q2 2021.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.